| Name | Title | Contact Details |
|---|---|---|
Michael Ciraolo |
Chief Operating Officer | Profile |
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
Advanced Accelerator Applications is a pharmaceutical group specialized in the field of nuclear medicine.
Capsugel is a Peapack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.